Mandate

Vinge represents Lassie AB in a capital raising of SEK 260 million

November 29, 2023 M&A

Vinge has advised the pet insurance broker Lassie AB in connection with a capital raising of SEK 260 million in order to continue the expansion of the business.

Lassie AB, whose business model is based on users reducing their insurance costs by collecting points through preventive animal care, was founded by Hedda Båverud Olsson, Johan Jönsson and Sophie Wilkinson and the company has grown rapidly since the first capital round just over two years ago.

The capital round, which was led by the British venture capital firm Balderton Capital, also involved a number of existing investors, including the institutional investors Felix Capital, Inventure and Passion Capital.

Vinge's team consisted of Filip Öhrner and Tim Axell.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025